science top stories popular news  

Daily non-political popular news in brief.

Staph vaccine shows promise in mouse study

10-30-2006 · EurekAlert!

By combining four proteins of Staphylococcus aureus that individually generated the strongest immune response in mice, scientists have created a vaccine that significantly protects the animals from diverse strains of the bacterium that cause disease in humans. A report describing the University of Chicago study, funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, appears online this week in the Proceedings of the National Academy of Sciences.

Read more »

Keywords: staph, vaccine, shows, promise, mouse, study, show

« Previous | Next »

Similar news on "Staph vaccine shows promise in mouse study":

  1. MRSA vaccine shows promise in mouse study
    10-30-2006 · EurekAlert!
    By combining the four bacterial surface proteins that generate the strongest immune response in mice, researchers at the University of Chicago have created a vaccine that significantly protects immunized animals from multiple disease-causing, drug-resistant strains of Staphylococcus aureus, the most common cause of hospital-acquired infections and a rapidly spreading source of community-associated illness.
    Similar news · Read more »
  2. Vaccine shows promise in preventing mono
    12-10-2007 · EurekAlert!
    A new study suggests that a vaccine targeting Epstein-Barr virus may prevent infectious mononucleosis, commonly known as "mono" or "glandular fever." The study is published in the Dec. 15 issue of the Journal of Infectious Diseases, now available online.
    Similar news · Read more »
  3. Novel MS drug shows promise in 2 lethal leukemias
    08-28-2007 · EurekAlert!
    A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
    Similar news · Read more »
  4. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
    06-02-2007 · EurekAlert!
    The study showed that sipuleucel-T did not significantly delay the time it took for a patient's PSA to reach a value of 3 ng/ml, the primary endpoint of the study, but it did show a prolongation in prostate-specific antigen doubling time (PSADT).
    Similar news · Read more »
  5. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinson's symptoms
    08-13-2007 · EurekAlert!
    New evidence indicates that the loss of two types of brain cells -- not just one as previously thought -- may trigger the onset of symptoms associated with Parkinson's disease. The evidence, based on mouse models, shows a link between the loss of both norepinephrine and dopamine neurons and the delayed onset of symptoms associated with Parkinson's disease. It was originally thought that the loss of only dopamine neurons triggered symptoms. Dopamine is a neurotransmitter critical for coordinating movement.
    Similar news · Read more »
  6. A longer-living, healthier mouse that could hold clues to human aging
    10-22-2007 · EurekAlert!
    A study by scientists at UCL shows that mice lacking the insulin receptor substrate-1 are more resistant to aging than normal mice. The research adds to a growing body of work showing the importance of insulin signaling pathways as an aging mechanism in mammals -- and potentially humans.
    Similar news · Read more »
  7. Blueberries contain chemical that may help prevent colon cancer
    03-25-2007 · EurekAlert!
    A compound in blueberries shows promise of preventing colon cancer in animals, according to a joint study by scientists at Rutgers University and the US Department of Agriculture. The compound, pterostilbene, is a potent antioxidant that could be developed into a pill with the potential for fewer side effects than some commercial drugs that are currently used to prevent the disease. The study will be presented in March during the American Chemical Society national meeting.
    Similar news · Read more »
  8. Study shows drug effective in treating, preventing breast cancer
    11-01-2007 · EurekAlert!
    A new study of an estrogen-derived drug shows promise as a treatment for breast cancer and breast cancer metastases to bone.
    Similar news · Read more »
  9. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
    08-01-2007 · EurekAlert!
    A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to research published in the Aug. 1 issue of the journal Clinical Cancer Research.
    Similar news · Read more »
  10. Study shows endemic cholera can be controlled with oral vaccines
    11-26-2007 · EurekAlert!
    Endemic cholera, a potentially fatal diarrheal disease found in the world's most impoverished countries, could be effectively controlled by orally vaccinating half of the affected populations once every two years for only pennies per dose, according to new findings by an international team of researchers led by Ira M. Longini Jr., Ph.D., a biostatistician in the Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center in Seattle.
    Similar news · Read more »